Cantabio was highlighted in last year’s World Economic Forum report titled “Top 10 Emerging Technologies 2019” as one of the top 10 emerging world-changing technologies for 2019. The report highlights technologies that are "disruptive, attractive to investors and researchers, and expected to have achieved considerable scale within five years”.
Cantabio was described as one of few leading companies in the world capable of therapeutically targeting intrinsically disordered proteins, a special class of promising drug targets for Alzheimer’s and cancer. The report identified Cantabio’s particular ability to target these types of proteins, previously considered by the pharmaceutical industry as impossible to target, for the development of promising new drugs in the areas of neurodegeneration and cancer.
News 
Market Data 
Discover 
